Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

Affiliations

• ¹ Haematology, Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia.
• ² University of Sydney, Camperdown, NSW, Australia.
• ³ Department of Haematology, Wollongong Hospital, NSW, Australia.
• ⁴ Department of Haematology and Medical Oncology, Western Health and University of Melbourne, St Albans, VIC, Australia.
• ⁵ Orange Hospital, NSW, Australia.
• ⁶ University of Sydney, Orange, NSW, Australia.
• ⁷ Princess Alexandra Hospital, Brisbane, QLD, Australia.
• ⁸ Mater Research University of Queensland, Brisbane, QLD, Australia.
• ⁹ Department of Haematology, Gold Coast University Hospital, Southport, Australia.
• ¹⁰ Griffith University, Southport, Australia.
• ¹¹ University of New South Wales, Sydney, NSW, Australia.
• ¹² Australasian Leukaemia and Lymphoma Group, Richmond, VIC, Australia.
• ¹³ WriteSource Medical Pty Ltd, Lane Cove, NSW, Australia.
• ¹⁴ Department of Molecular Imaging, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
• ¹⁵ Department of Hematology, Royal Hobart Hospital, Hobart, TAS, Australia.
• ¹⁶ University of Tasmania, Hobart, TAS, Australia.